TGRNF (Tong Ren Tang Technologies Co) 5-Year RORE % : -11.70% (As of Dec. 2025)


TGRNF Tong Ren Tang Technologies Co Ltd TGRNF
50 GF Score
Price $0.49
GF Value $0.84
Valuation Significantly Undervalued
! 5 Warning Signs
View Full Analysis

What is Tong Ren Tang Technologies Co 5-Year RORE %?

Tong Ren Tang Technologies Co TGRNF 50 5-Year RORE % is -11.70 as of Dec. 2025. GuruFocus rates TGRNF with a GF Score™ of 50/100 and a GF Value™ of $0.84 (Significantly Undervalued). The stock has 5 warning signs investors should review. Among 879 Drug Manufacturers companies, Tong Ren Tang Technologies Co ranks worse than 64.73% on this metric.

Return on Retained Earnings (RORE) is an indicator of a company's growth potential, it shows how much a company earns by reinvesting its retained earnings, i.e. profits after dividend payments. Tong Ren Tang Technologies Co's 5-Year RORE % for the quarter that ended in Dec. 2025 was -11.70%.

The industry rank for Tong Ren Tang Technologies Co's 5-Year RORE % or its related term are showing as below:

TGRNF's 5-Year RORE % is ranked worse than
64.73% of 879 companies
in the Drug Manufacturers industry
Industry Median: 1.37 vs TGRNF: -11.70

Tong Ren Tang Technologies Co  (OTCPK:TGRNF) 5-Year RORE % Explanation

Return on Retained Earnings (RORE) is important to investors because it reveals a company's efficiency and growth potential. A higher RORE indicates a higher return. A high RORE indicates that the company should reinvest profits into the business. A lower RORE suggests that the company should distribute profits to shareholders by paying out dividends, since those dollars aren't generating much additional growth for the company.

There are a several different ways to arrive at the Return on Retained Earnings. The simplest way to calculate it is by using published information on Earnings per Share (EPS) and Dividend per Share (DPS) over a selected period. Here, 5-year period is chosen.

Be Aware

Please keep in mind that the RORE is relative to the nature of the business and its competitors. If another company in the same sector is producing a lower return on retained earnings, it doesn’t necessarily mean it’s a bad investment. It may just suggest the company is older and no longer in a high growth stage. At such a stage in the business cycle, it would be expected to see a lower RORE and higher dividend payout.


Tong Ren Tang Technologies Co 5-Year RORE % Related Terms


Tong Ren Tang Technologies Co 5-Year RORE % Historical Data

* Premium members only.

The historical data trend for Tong Ren Tang Technologies Co's 5-Year RORE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Tong Ren Tang Technologies Co 5-Year RORE % Chart

Tong Ren Tang Technologies Co Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
5-Year RORE %
Get a 7-Day Free Trial Premium Member Only Premium Member Only -7.07 -7.49 9.77 1.09 -11.70

Tong Ren Tang Technologies Co Semi-Annual Data
Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
5-Year RORE % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 9.77 19.77 1.09 -8.51 -11.70

TGRNF vs LLY, JNJ, ABBV: 5-Year RORE % Comparison

For the Drug Manufacturers - General subindustry, Tong Ren Tang Technologies Co's 5-Year RORE %, along with its competitors' market caps and 5-Year RORE % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Tong Ren Tang Technologies Co 5-Year RORE % vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Tong Ren Tang Technologies Co's 5-Year RORE % distribution charts can be found below:

* The bar in red indicates where Tong Ren Tang Technologies Co's 5-Year RORE % falls into.


TGRNF
50GF Score
Tong Ren Tang Technologies Co Ltd TGRNF
5-Year RORE % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Tong Ren Tang Technologies Co 5-Year RORE % Calculation

Tong Ren Tang Technologies Co's 5-Year RORE % for the quarter that ended in Dec. 2025 is calculated as:

5-Year RORE %=( Most Recent EPS (Diluted)- First Period EPS (Diluted) )/( Cumulative EPS (Diluted) for 5-year -Cumulative Dividends per Share for 5-year )
=( 0.043-0.063 )/( 0.293-0.122 )
=-0.02/0.171
=-11.70 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of 5-Year RORE %, the most recent and first period EPS (Diluted) is the trailing twelve months (TTM) data ended in Dec. 2025 and 5-year before.

Frequently Asked Questions Learn more about 5-Year RORE % →
What does a 5-Year RORE % of -11.70 mean?
Tong Ren Tang Technologies Co (TGRNF) has a 5-Year RORE % of -11.70 as of Dec. 2025. 5-Year RORE % shows how much a company earns by reinvesting its retained earnings in 5-year. View historical data on Tong Ren Tang Technologies Co and its competitors. According to the industry distribution chart, Tong Ren Tang Technologies Co ranks #569 out of 879 companies in the Drug Manufacturers industry, placing it in the top 64.7%.
Is Tong Ren Tang Technologies Co's 5-Year RORE % too high?
Tong Ren Tang Technologies Co's current 5-Year RORE % is -11.70. Based on the distribution chart, Tong Ren Tang Technologies Co ranks #569 out of 879 companies in the Drug Manufacturers industry, which is below the industry midpoint. Overall, Tong Ren Tang Technologies Co has a GF Score™ of 50/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Tong Ren Tang Technologies Co's 5-Year RORE % compare to LLY and JNJ?
According to the Drug Manufacturers industry distribution chart, Tong Ren Tang Technologies Co ranks #569 out of 879 companies for 5-Year RORE %. This places Tong Ren Tang Technologies Co in the lower half of its industry. The industry median 5-Year RORE % is 1.37. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 5-Year RORE % for a Drug Manufacturers company?
The median 5-Year RORE % among Drug Manufacturers companies is 1.37, based on 879 companies in the industry. Companies in the top quartile (top 25%) have a 5-Year RORE % significantly above this median, while those in the bottom quartile fall well below. However, 5-Year RORE % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 5-Year RORE % mean?
A high 5-Year RORE % can signal that a stock is expensive relative to its fundamentals. 5-Year RORE % shows how much a company earns by reinvesting its retained earnings in 5-year. View historical data on Tong Ren Tang Technologies Co and its competitors. For the Drug Manufacturers industry, the median 5-Year RORE % is 1.37 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Tong Ren Tang Technologies Co's current 5-Year RORE % is -11.70. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Tong Ren Tang Technologies Co stock overvalued right now?
Based on GuruFocus' analysis, Tong Ren Tang Technologies Co (TGRNF) is currently considered Significantly Undervalued. The stock's GF Value™ is $0.84, compared to a current price of $0.49 — trading 41.1% below its estimated fair value. The current 5-Year RORE % is -11.70. Tong Ren Tang Technologies Co's overall GF Score™ is 50/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 5-Year RORE % calculated?
5-Year RORE % is calculated from a company's financial statements. For Tong Ren Tang Technologies Co (TGRNF), the current 5-Year RORE % is -11.70 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Tong Ren Tang Technologies Co (TGRNF) Overvalued in 2026?

Based on GuruFocus' analysis, Tong Ren Tang Technologies Co stock appears to be undervalued. The current stock price of $0.49 is trading 41.1% below its estimated GF Value™ of $0.84. GuruFocus considers Tong Ren Tang Technologies Co to be Significantly Undervalued.

Key valuation signals for TGRNF:

  • 5-Year RORE %: -11.70
  • GF Value™: $0.84 vs. price of $0.49 (41.1% below fair value)
  • GF Score™: 50/100 with 5 warning signs

No single metric tells the full story. See the TGRNF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Tong Ren Tang Technologies Co Business Description

Other Exchanges 01666:Hong KongTNG:Germany
Address No. 16 Tongji Beilu, Beijing Economic and Technological Development Zone, Beijing, CHN
Tong Ren Tang Technologies Co Ltd is engaged in the production and distribution of Chinese medicine and predominantly operates in Mainland China and Hong Kong. The operating segments derive their revenue predominantly from the manufacture and sale of Chinese medicine of the company in Mainland China and Tong Ren Tang Chinese Medicine and its subsidiaries engaged in manufacturing, retail, and wholesale of Chinese medicine products and healthcare products, and provision of Chinese medical consultation and treatments outside Mainland China and wholesale of healthcare products in Mainland China.
50GF Score

Get the complete analysis for TGRNF

5-Year RORE % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.49
Price
$0.84
GF Value